Jared Klarquist
Concepts (267)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
T-Lymphocytes, Helper-Inducer | 4 | 2021 | 128 | 1.580 |
Why?
| Lupus Erythematosus, Systemic | 4 | 2020 | 221 | 1.560 |
Why?
| CD8-Positive T-Lymphocytes | 8 | 2023 | 691 | 1.520 |
Why?
| Vitiligo | 8 | 2016 | 52 | 1.420 |
Why?
| Vaccines, Subunit | 2 | 2021 | 41 | 1.370 |
Why?
| B-Lymphocytes | 4 | 2021 | 772 | 1.200 |
Why?
| T-Lymphocytes, Regulatory | 5 | 2016 | 340 | 0.890 |
Why?
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 93 | 0.880 |
Why?
| Interleukin-27 | 1 | 2021 | 11 | 0.780 |
Why?
| Skin | 5 | 2016 | 659 | 0.780 |
Why?
| Interferon Type I | 2 | 2020 | 128 | 0.760 |
Why?
| Immunologic Memory | 3 | 2023 | 313 | 0.720 |
Why?
| Epitopes, T-Lymphocyte | 1 | 2021 | 170 | 0.690 |
Why?
| gp100 Melanoma Antigen | 3 | 2016 | 3 | 0.650 |
Why?
| Melanoma | 5 | 2016 | 622 | 0.570 |
Why?
| Dendritic Cells | 4 | 2016 | 436 | 0.560 |
Why?
| Chemokine CCL22 | 1 | 2016 | 3 | 0.560 |
Why?
| Mice, Inbred C57BL | 13 | 2023 | 4718 | 0.540 |
Why?
| Receptors, Antigen, T-Cell | 3 | 2016 | 618 | 0.500 |
Why?
| Disease Models, Animal | 6 | 2020 | 3545 | 0.460 |
Why?
| Lymphangioleiomyomatosis | 2 | 2013 | 27 | 0.440 |
Why?
| Mice | 16 | 2023 | 14927 | 0.410 |
Why?
| Neoplasm Proteins | 2 | 2018 | 385 | 0.400 |
Why?
| Autoimmunity | 2 | 2014 | 818 | 0.390 |
Why?
| T-Lymphocytes | 2 | 2018 | 1747 | 0.380 |
Why?
| T-Lymphocytes, Cytotoxic | 3 | 2011 | 155 | 0.370 |
Why?
| Membrane Glycoproteins | 2 | 2010 | 429 | 0.360 |
Why?
| Animals | 19 | 2023 | 31867 | 0.360 |
Why?
| Mice, Knockout | 7 | 2020 | 2585 | 0.360 |
Why?
| Melanocytes | 5 | 2014 | 55 | 0.330 |
Why?
| Cytotoxicity, Immunologic | 1 | 2009 | 196 | 0.330 |
Why?
| CD4-Positive T-Lymphocytes | 5 | 2021 | 965 | 0.320 |
Why?
| Membrane Proteins | 1 | 2014 | 1019 | 0.320 |
Why?
| T-Lymphocyte Subsets | 4 | 2014 | 383 | 0.310 |
Why?
| Vaccination | 4 | 2021 | 1205 | 0.310 |
Why?
| Antigens, Neoplasm | 1 | 2009 | 222 | 0.310 |
Why?
| DNA | 1 | 2014 | 1352 | 0.300 |
Why?
| Germinal Center | 2 | 2020 | 49 | 0.300 |
Why?
| Hepatitis C | 5 | 2008 | 226 | 0.300 |
Why?
| Hepacivirus | 5 | 2008 | 233 | 0.270 |
Why?
| Up-Regulation | 4 | 2018 | 812 | 0.260 |
Why?
| Hepatitis C, Chronic | 4 | 2008 | 152 | 0.250 |
Why?
| Gangliosides | 2 | 2016 | 18 | 0.250 |
Why?
| Receptors, CCR4 | 2 | 2016 | 15 | 0.230 |
Why?
| Flow Cytometry | 5 | 2017 | 1084 | 0.230 |
Why?
| Lysophospholipids | 1 | 2023 | 65 | 0.210 |
Why?
| Phenols | 3 | 2014 | 82 | 0.200 |
Why?
| Lymphocyte Count | 1 | 2021 | 133 | 0.190 |
Why?
| Receptors, Virus | 1 | 2021 | 75 | 0.190 |
Why?
| Neoplasms | 1 | 2014 | 2106 | 0.190 |
Why?
| HSP70 Heat-Shock Proteins | 2 | 2014 | 61 | 0.190 |
Why?
| Mice, Transgenic | 5 | 2018 | 1955 | 0.180 |
Why?
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2020 | 6 | 0.180 |
Why?
| Receptor, Interferon alpha-beta | 1 | 2020 | 22 | 0.180 |
Why?
| Transcriptional Activation | 2 | 2018 | 337 | 0.160 |
Why?
| Aerobiosis | 1 | 2018 | 20 | 0.160 |
Why?
| Vaccinia | 1 | 2018 | 18 | 0.160 |
Why?
| Ovalbumin | 1 | 2018 | 162 | 0.150 |
Why?
| B7-H1 Antigen | 2 | 2018 | 139 | 0.150 |
Why?
| Interleukin-15 | 1 | 2018 | 75 | 0.150 |
Why?
| Orthomyxoviridae Infections | 1 | 2018 | 54 | 0.150 |
Why?
| Antiviral Agents | 3 | 2008 | 647 | 0.150 |
Why?
| Cells, Cultured | 4 | 2020 | 3896 | 0.150 |
Why?
| Receptors, Interleukin-17 | 1 | 2017 | 5 | 0.150 |
Why?
| Glycolysis | 1 | 2018 | 227 | 0.140 |
Why?
| Protein Tyrosine Phosphatases | 1 | 2018 | 147 | 0.140 |
Why?
| Adjuvants, Immunologic | 1 | 2018 | 206 | 0.140 |
Why?
| Killer Cells, Natural | 1 | 2020 | 383 | 0.140 |
Why?
| Housing, Animal | 1 | 2017 | 43 | 0.140 |
Why?
| Apoptosis Regulatory Proteins | 2 | 2008 | 172 | 0.140 |
Why?
| Sialyltransferases | 1 | 2016 | 13 | 0.140 |
Why?
| Humans | 26 | 2021 | 115042 | 0.140 |
Why?
| Stress, Physiological | 2 | 2017 | 377 | 0.140 |
Why?
| Female | 17 | 2020 | 59613 | 0.140 |
Why?
| Interleukins | 1 | 2018 | 236 | 0.140 |
Why?
| Macrophages, Peritoneal | 1 | 2016 | 91 | 0.140 |
Why?
| Transcription Factor RelA | 1 | 2016 | 83 | 0.130 |
Why?
| Epidermis | 2 | 2014 | 149 | 0.130 |
Why?
| Melanoma, Experimental | 1 | 2016 | 89 | 0.130 |
Why?
| Jurkat Cells | 1 | 2016 | 127 | 0.130 |
Why?
| Triple Negative Breast Neoplasms | 1 | 2018 | 157 | 0.130 |
Why?
| Diet, High-Fat | 1 | 2017 | 225 | 0.130 |
Why?
| CD8 Antigens | 1 | 2015 | 69 | 0.130 |
Why?
| Cell Death | 2 | 2014 | 324 | 0.130 |
Why?
| Clone Cells | 1 | 2016 | 248 | 0.130 |
Why?
| Intramolecular Oxidoreductases | 3 | 2011 | 57 | 0.130 |
Why?
| Antigens, CD | 2 | 2008 | 441 | 0.120 |
Why?
| Plaque, Atherosclerotic | 1 | 2015 | 44 | 0.120 |
Why?
| Interferon Regulatory Factor-3 | 1 | 2014 | 17 | 0.120 |
Why?
| Allergens | 1 | 2018 | 417 | 0.120 |
Why?
| Cloning, Molecular | 1 | 2016 | 524 | 0.120 |
Why?
| Hyperlipidemias | 1 | 2015 | 122 | 0.120 |
Why?
| Skin Pigmentation | 3 | 2011 | 39 | 0.120 |
Why?
| Hypopigmentation | 1 | 2014 | 2 | 0.120 |
Why?
| Toll-Like Receptor 4 | 1 | 2017 | 286 | 0.120 |
Why?
| Temperature | 1 | 2017 | 578 | 0.120 |
Why?
| Base Sequence | 2 | 2016 | 2119 | 0.120 |
Why?
| B-Lymphocyte Subsets | 1 | 2014 | 68 | 0.120 |
Why?
| Pigmentation | 1 | 2014 | 55 | 0.110 |
Why?
| Hydroquinones | 2 | 2014 | 27 | 0.110 |
Why?
| Non-alcoholic Fatty Liver Disease | 1 | 2017 | 246 | 0.110 |
Why?
| Male | 15 | 2020 | 55731 | 0.110 |
Why?
| Immunity | 1 | 2014 | 121 | 0.110 |
Why?
| Skin Neoplasms | 2 | 2011 | 758 | 0.110 |
Why?
| Antigens | 1 | 2014 | 318 | 0.110 |
Why?
| Oxidoreductases | 2 | 2011 | 92 | 0.110 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 1144 | 0.110 |
Why?
| Lymphocytes, Tumor-Infiltrating | 2 | 2012 | 111 | 0.100 |
Why?
| Interferon-gamma | 4 | 2008 | 723 | 0.100 |
Why?
| Atherosclerosis | 1 | 2015 | 342 | 0.100 |
Why?
| HSP72 Heat-Shock Proteins | 1 | 2011 | 26 | 0.100 |
Why?
| Neoplasms, Experimental | 1 | 2012 | 151 | 0.100 |
Why?
| Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 797 | 0.100 |
Why?
| DNA-Binding Proteins | 1 | 2018 | 1318 | 0.090 |
Why?
| Cell Proliferation | 2 | 2016 | 2191 | 0.090 |
Why?
| Heme Oxygenase-1 | 1 | 2011 | 52 | 0.090 |
Why?
| Sepsis | 1 | 2016 | 508 | 0.090 |
Why?
| Ribavirin | 2 | 2008 | 89 | 0.090 |
Why?
| Immunotherapy, Adoptive | 1 | 2012 | 184 | 0.090 |
Why?
| Receptors, CCR8 | 1 | 2010 | 2 | 0.090 |
Why?
| Forkhead Transcription Factors | 2 | 2008 | 171 | 0.090 |
Why?
| Antigens, Differentiation, T-Lymphocyte | 1 | 2010 | 84 | 0.090 |
Why?
| Interferon-alpha | 2 | 2008 | 186 | 0.090 |
Why?
| MART-1 Antigen | 1 | 2009 | 10 | 0.090 |
Why?
| Receptors, CCR5 | 1 | 2010 | 54 | 0.090 |
Why?
| Macrophages | 1 | 2016 | 1267 | 0.090 |
Why?
| Microscopy, Electron, Transmission | 1 | 2009 | 136 | 0.080 |
Why?
| Adult | 9 | 2016 | 30656 | 0.080 |
Why?
| Autoimmune Diseases | 2 | 2011 | 394 | 0.080 |
Why?
| Cell Separation | 1 | 2009 | 291 | 0.080 |
Why?
| Convalescence | 1 | 2007 | 15 | 0.070 |
Why?
| Disease Transmission, Infectious | 1 | 2007 | 56 | 0.070 |
Why?
| Signal Transduction | 2 | 2023 | 4525 | 0.070 |
Why?
| Biomarkers, Tumor | 1 | 2013 | 1045 | 0.070 |
Why?
| Interleukin-7 Receptor alpha Subunit | 1 | 2006 | 11 | 0.070 |
Why?
| Receptors, Interleukin-7 | 1 | 2006 | 25 | 0.070 |
Why?
| Polyethylene Glycols | 2 | 2008 | 561 | 0.070 |
Why?
| Epitopes | 3 | 2015 | 436 | 0.070 |
Why?
| Immunotherapy | 1 | 2009 | 474 | 0.060 |
Why?
| Immunohistochemistry | 1 | 2009 | 1634 | 0.060 |
Why?
| Obesity | 1 | 2017 | 2524 | 0.060 |
Why?
| Middle Aged | 9 | 2014 | 26827 | 0.060 |
Why?
| Monitoring, Immunologic | 1 | 2023 | 23 | 0.050 |
Why?
| Receptors, Lysophosphatidic Acid | 1 | 2023 | 29 | 0.050 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2017 | 928 | 0.050 |
Why?
| Listeria monocytogenes | 1 | 2023 | 111 | 0.050 |
Why?
| Lung Neoplasms | 1 | 2013 | 2201 | 0.040 |
Why?
| Adolescent | 4 | 2014 | 17864 | 0.040 |
Why?
| Young Adult | 2 | 2014 | 10498 | 0.040 |
Why?
| Cell Survival | 2 | 2014 | 1022 | 0.040 |
Why?
| Sex Factors | 2 | 2017 | 1721 | 0.040 |
Why?
| Jejunum | 1 | 2017 | 24 | 0.040 |
Why?
| Cell Line, Tumor | 2 | 2016 | 2715 | 0.040 |
Why?
| Th1 Cells | 2 | 2008 | 123 | 0.040 |
Why?
| Gram-Negative Bacteria | 1 | 2017 | 66 | 0.040 |
Why?
| Biolistics | 1 | 2016 | 1 | 0.040 |
Why?
| Permeability | 1 | 2017 | 148 | 0.040 |
Why?
| Viremia | 2 | 2008 | 122 | 0.040 |
Why?
| CCAAT-Enhancer-Binding Proteins | 1 | 2016 | 34 | 0.030 |
Why?
| Vaccines, DNA | 1 | 2016 | 30 | 0.030 |
Why?
| Cold Temperature | 1 | 2017 | 129 | 0.030 |
Why?
| Disease Progression | 2 | 2017 | 2389 | 0.030 |
Why?
| Cytomegalovirus | 2 | 2007 | 145 | 0.030 |
Why?
| Cell Differentiation | 1 | 2023 | 1700 | 0.030 |
Why?
| Corticosterone | 1 | 2017 | 211 | 0.030 |
Why?
| Programmed Cell Death 1 Receptor | 2 | 2008 | 193 | 0.030 |
Why?
| Receptors, LDL | 1 | 2015 | 38 | 0.030 |
Why?
| Basic-Leucine Zipper Transcription Factors | 1 | 2015 | 39 | 0.030 |
Why?
| Transcription Factors | 1 | 2023 | 1531 | 0.030 |
Why?
| Alleles | 2 | 2008 | 792 | 0.030 |
Why?
| Monophenol Monooxygenase | 1 | 2014 | 9 | 0.030 |
Why?
| Stem Cell Factor | 1 | 2014 | 14 | 0.030 |
Why?
| Recombinant Proteins | 2 | 2008 | 1237 | 0.030 |
Why?
| Antigen Presentation | 1 | 2015 | 189 | 0.030 |
Why?
| Bone Marrow Cells | 1 | 2015 | 267 | 0.030 |
Why?
| Acute Disease | 2 | 2008 | 915 | 0.030 |
Why?
| Interleukin-1beta | 1 | 2016 | 370 | 0.030 |
Why?
| HEK293 Cells | 1 | 2016 | 590 | 0.030 |
Why?
| Inflammation | 2 | 2017 | 2485 | 0.030 |
Why?
| Melanosomes | 1 | 2014 | 2 | 0.030 |
Why?
| Trans-Activators | 1 | 2016 | 368 | 0.030 |
Why?
| Hematopoietic Stem Cells | 1 | 2017 | 344 | 0.030 |
Why?
| Subcellular Fractions | 1 | 2014 | 78 | 0.030 |
Why?
| Machine Learning | 1 | 2017 | 318 | 0.030 |
Why?
| Interleukin-17 | 1 | 2014 | 104 | 0.030 |
Why?
| Spleen | 1 | 2015 | 486 | 0.030 |
Why?
| RNA, Viral | 2 | 2007 | 567 | 0.030 |
Why?
| Intracellular Space | 1 | 2014 | 68 | 0.030 |
Why?
| Case-Control Studies | 2 | 2013 | 3015 | 0.030 |
Why?
| Transgenes | 1 | 2014 | 170 | 0.030 |
Why?
| Lipopolysaccharides | 1 | 2016 | 817 | 0.030 |
Why?
| Antigens, CD1d | 1 | 2013 | 63 | 0.030 |
Why?
| Proto-Oncogene Proteins | 1 | 2016 | 609 | 0.030 |
Why?
| Lymph Nodes | 1 | 2015 | 422 | 0.030 |
Why?
| Interleukin-6 | 1 | 2016 | 676 | 0.030 |
Why?
| Natural Killer T-Cells | 1 | 2013 | 63 | 0.030 |
Why?
| Repressor Proteins | 1 | 2015 | 368 | 0.030 |
Why?
| HLA-A2 Antigen | 1 | 2012 | 37 | 0.030 |
Why?
| Intestinal Mucosa | 1 | 2017 | 528 | 0.030 |
Why?
| Promoter Regions, Genetic | 1 | 2016 | 1133 | 0.030 |
Why?
| Protein Transport | 1 | 2014 | 398 | 0.030 |
Why?
| CD3 Complex | 1 | 2012 | 92 | 0.030 |
Why?
| Longitudinal Studies | 2 | 2008 | 2389 | 0.020 |
Why?
| Bleaching Agents | 1 | 2011 | 1 | 0.020 |
Why?
| Tumor Cells, Cultured | 1 | 2013 | 851 | 0.020 |
Why?
| Langerhans Cells | 1 | 2011 | 11 | 0.020 |
Why?
| PUVA Therapy | 1 | 2011 | 5 | 0.020 |
Why?
| Heme Oxygenase (Decyclizing) | 1 | 2011 | 21 | 0.020 |
Why?
| Gastrointestinal Microbiome | 1 | 2017 | 502 | 0.020 |
Why?
| Administration, Topical | 1 | 2011 | 138 | 0.020 |
Why?
| Gene Expression Profiling | 1 | 2017 | 1523 | 0.020 |
Why?
| Annexin A5 | 1 | 2010 | 22 | 0.020 |
Why?
| DNA Fragmentation | 1 | 2010 | 47 | 0.020 |
Why?
| Poly(ADP-ribose) Polymerases | 1 | 2010 | 88 | 0.020 |
Why?
| Organ Culture Techniques | 1 | 2010 | 141 | 0.020 |
Why?
| Necrosis | 1 | 2010 | 210 | 0.020 |
Why?
| Endoplasmic Reticulum | 1 | 2011 | 234 | 0.020 |
Why?
| Caspase 3 | 1 | 2010 | 237 | 0.020 |
Why?
| Autoantigens | 1 | 2011 | 397 | 0.020 |
Why?
| Cell Line | 1 | 2014 | 2645 | 0.020 |
Why?
| Keratinocytes | 1 | 2010 | 216 | 0.020 |
Why?
| Ultraviolet Rays | 1 | 2011 | 368 | 0.020 |
Why?
| Fibrinogens, Abnormal | 1 | 2008 | 4 | 0.020 |
Why?
| Cohort Studies | 2 | 2008 | 4904 | 0.020 |
Why?
| CD24 Antigen | 1 | 2008 | 20 | 0.020 |
Why?
| Remission, Spontaneous | 1 | 2007 | 37 | 0.020 |
Why?
| Interleukin-2 Receptor alpha Subunit | 1 | 2008 | 66 | 0.020 |
Why?
| Programmed Cell Death 1 Ligand 2 Protein | 1 | 2007 | 14 | 0.020 |
Why?
| CD57 Antigens | 1 | 2007 | 15 | 0.020 |
Why?
| CD4 Antigens | 1 | 2007 | 124 | 0.020 |
Why?
| Genes, MHC Class II | 1 | 2007 | 70 | 0.020 |
Why?
| Antioxidants | 1 | 2011 | 530 | 0.020 |
Why?
| Mice, Inbred Strains | 1 | 2008 | 398 | 0.020 |
Why?
| Blood | 1 | 2007 | 97 | 0.020 |
Why?
| Age Distribution | 1 | 2007 | 340 | 0.020 |
Why?
| Protein Isoforms | 1 | 2008 | 339 | 0.020 |
Why?
| Histocompatibility Antigens Class I | 1 | 2008 | 174 | 0.020 |
Why?
| Aged, 80 and over | 2 | 2008 | 6357 | 0.020 |
Why?
| HLA Antigens | 1 | 2008 | 224 | 0.020 |
Why?
| Immunoglobulin M | 1 | 2007 | 251 | 0.020 |
Why?
| Prospective Studies | 2 | 2008 | 6232 | 0.020 |
Why?
| Immunity, Cellular | 1 | 2008 | 249 | 0.020 |
Why?
| Interleukin-2 | 1 | 2007 | 415 | 0.020 |
Why?
| Viral Load | 1 | 2007 | 405 | 0.020 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2007 | 349 | 0.020 |
Why?
| Drug Therapy, Combination | 1 | 2008 | 955 | 0.020 |
Why?
| Fibroblasts | 1 | 2010 | 839 | 0.020 |
Why?
| Cytomegalovirus Infections | 1 | 2007 | 182 | 0.020 |
Why?
| RNA | 1 | 2011 | 810 | 0.020 |
Why?
| Oxidative Stress | 1 | 2011 | 1085 | 0.020 |
Why?
| Polymerase Chain Reaction | 1 | 2007 | 999 | 0.020 |
Why?
| Antibodies, Viral | 1 | 2007 | 522 | 0.010 |
Why?
| Sexual Behavior | 1 | 2007 | 440 | 0.010 |
Why?
| Infant, Newborn | 1 | 2014 | 5040 | 0.010 |
Why?
| Predictive Value of Tests | 1 | 2008 | 1812 | 0.010 |
Why?
| Genotype | 1 | 2008 | 1780 | 0.010 |
Why?
| Antibodies, Monoclonal | 1 | 2007 | 1268 | 0.010 |
Why?
| Apoptosis | 1 | 2010 | 2366 | 0.010 |
Why?
| Lung | 1 | 2013 | 3595 | 0.010 |
Why?
| Biomarkers | 1 | 2010 | 3419 | 0.010 |
Why?
| Liver | 1 | 2007 | 1681 | 0.010 |
Why?
| Phenotype | 1 | 2006 | 2815 | 0.010 |
Why?
| Surveys and Questionnaires | 1 | 2007 | 4631 | 0.010 |
Why?
| Treatment Outcome | 1 | 2008 | 9122 | 0.010 |
Why?
| Risk Factors | 1 | 2007 | 8642 | 0.010 |
Why?
| United States | 1 | 2007 | 12226 | 0.010 |
Why?
| Aged | 1 | 2007 | 19119 | 0.010 |
Why?
|
|
Klarquist's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts ![Expand Description](https://profiles.ucdenver.edu/Framework/Images/info.png) Derived automatically from this person's publications. _
Co-Authors ![Expand Description](https://profiles.ucdenver.edu/Framework/Images/info.png) People in Profiles who have published with this person. _
Similar People ![Expand Description](https://profiles.ucdenver.edu/Framework/Images/info.png) People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors ![Expand Description](https://profiles.ucdenver.edu/Framework/Images/info.png) People whose addresses are nearby this person. _
|